ConductScience.org, home

Paper · 20161474

Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.

Boltje TJ and 2 others. Nat Chem, 2009. Cited by 502 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Papers, record 20161474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161474

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.
PubMed
Journal
Nat Chem
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
502
iCite
Relative citation ratio, by iCite
14.7
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boltje TJThomas J
2Buskas TTherese
3Boons GJGeert-Jan

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycoconjugatesMajor topic
OligosaccharidesMajor topic
Amino Acid Sequence
Enzymes
Glycomics
Glycosylation
Humans
Molecular Sequence Data
Polymers

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 GM061761NIGMS NIH HHSUnited StatesR01GM061761PubMed and NIHNIH RePORTER
2R01GM065248NIGMS NIH HHSUnited StatesR01GM065248PubMed and NIHNIH RePORTER
R01CA088986NCI NIH HHSUnited StatesR01CA088986PubMed and NIHNIH RePORTER
R01 GM065248NIGMS NIH HHSUnited StatesR01GM065248PubMed and NIHNIH RePORTER
R01 CA088986NCI NIH HHSUnited StatesR01CA088986PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,100,617Thioglycosides in sequential glycosylation strategies.Chem Soc Rev2005https://conductscience.org/library/papers/16100617PubMed
217,672,460Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition.J Am Chem Soc2007https://conductscience.org/library/papers/17672460PubMed
319,240,943Lessons learned from the contamination of heparin.Nat Prod Rep2009https://conductscience.org/library/papers/19240943PubMed
416,953,636Practical approach for the stereoselective introduction of beta-arabinofuranosides.J Am Chem Soc2006https://conductscience.org/library/papers/16953636PubMed
517,134,948Strategies for analysis of glycoprotein glycosylation.Biochim Biophys Acta2006https://conductscience.org/library/papers/17134948PubMed
618,437,154Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.Nat Biotechnol2008https://conductscience.org/library/papers/18437154PubMed
712,588,327Carbohydrate-protein conjugate vaccines.Clin Microbiol Infect2003https://conductscience.org/library/papers/12588327PubMed
819,216,499Synthesis and applications of a light-fluorous glycosyl donor.J Org Chem2009https://conductscience.org/library/papers/19216499PubMed
919,093,879Glycoprotein synthesis: an update.Chem Rev2009https://conductscience.org/library/papers/19093879PubMed
1010,978,329Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues.J Biol Chem2000https://conductscience.org/library/papers/10978329PubMed

Cited by185

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 502 citations.

PMIDTitleJournalYearIn PapersSource
42,912,858Synthesis of 2,3-Diamino-2,3-Dideoxy-β-d-Mannosides via Stereoselective Anomeric O-Alkylation of 2N,3N-Imidazolidinone-Protected d-Mannoses.J Org Chem2026https://conductscience.org/library/papers/42912858PubMed
42,439,377Charting the Future of Stereoselective Carbohydrate Synthesis: The Essential Role of Cross-Disciplinary Innovation.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42439377PubMed
42,333,892Chemical Synthesis and Immunological Evaluation of Escherichia coli O29, Shigella dysenteriae Serotype 11, and Proteus vulgaris O12 O-Antigen Oligosaccharides.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42333892PubMed
42,329,121Chemoenzymatic Synthesis of Asymmetric N-Glycans in Aqueous Solution via Sulfate and Phosphate Orthogonal Protection.J Am Chem Soc2026https://conductscience.org/library/papers/42329121PubMed
42,164,338Process Safety Assessment of the Iron-Catalyzed 1,2-cis-Selective Glycal Aminoglycosylation.Org Process Res Dev2026https://conductscience.org/library/papers/42164338PubMed
42,120,876Identification and quantification of intracellular N-acetylglucosamine modified glycoRNAs.Nat Commun2026https://conductscience.org/library/papers/42120876PubMed
41,725,592Elucidating the Stereodirecting Effect of C-4 Acyl Groups on Galactosyl Donors.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/41725592PubMed
41,723,115Ligand-enabled next-generation glycosyl Stille cross-coupling for the stereospecific synthesis of sterically hindered aryl C-glycosides.Nat Commun2026https://conductscience.org/library/papers/41723115PubMed
41,684,750Process Safety Assessment of the Iron-Catalyzed 1,2-cis-Selective Glycal Aminoglycosylation.Res Sq2026https://conductscience.org/library/papers/41684750PubMed
41,632,009Identification of Mannose-Capped-Arabinomannan 101-mer as a Potential Influenza Virus Vaccine Adjuvant.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41632009PubMed

1 to 10 of 185

See all 185 cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20161474

GET https://conductscience.org/api/papers/v1/20161474/references?page=2